Not Yet RecruitingNCT07851259
A Study to Assess the Efficacy and Safety of RO7965032 in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
PHASE2 · 321 planned enrolment
- Countries listed
- 0
- Registry update
- October 1, 2026
